|
|
Industry Alerts
The MHA works to keep its member
hospitals and health systems apprised of alerts that affect health care
patient safety and quality, such as notices from the Food and Drug
Administration (FDA) regarding device recalls, drug shortages and more.
Current pertinent industry alerts include:
-
On March 21, the US Food and Drug Administration announced a
voluntary recall of all sterile products from Clinical Specialties
Compounding Pharmacy (CSCP) of Augusta, GA, after reports of serious
patient eye infections. Michigan health care providers are urged to
review their inventory for products produced or distributed by CSCP
and stop using them immediately, and return the products. For
additional details about the recall and affected lots, see the
FDA announcement.
-
New England Compounding Center recall of all products compounded by their facility in Framingham, MA, due to risk of
contamination and possible linkage to nationwide fungal meningitis
outbreak. For full FDA recall announcement, visit their site here.
For a complete list of
FDA recalls, shortages and alerts, visit its
safety website.
|
